drugset / Trial / NCT00143728
3TC or No 3TC for HIV With 3TC Resistance
Phase 4
Suspended
152 enrolled
University of British Columbia
CIHR Canadian HIV Trials Network · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the effects of continuing or discontinuing 3TC treatment in the presence of HIV virus with 3TC resistance for persons who are on a regimen including least three other anti-HIV drugs. The overall aim is to determine whether continuing 3TC is of benefit in HIV-positive persons who have already shown resistance to this drug.
Timeline
- Start
- 2004-01
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamivudine | Other / unclassified | — | — |